Navigation Links
PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
Date:3/11/2013

harma logo are considered trademarks of PDL BioPharma, Inc.

Forward-looking Statements
This press release contains forward-looking statements. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Factors that may cause differences between current expectations and actual results include, but are not limited to, the following:

  • The expected rate of growth in royalty-bearing product sales by PDL's existing licensees;
  • The relative mix of royalty-bearing Genentech products manufactured and sold outside the U.S. versus made or sold in the U.S.;
  • The ability of our licensees to receive regulatory approvals to market and launch new royalty-bearing products and whether such products, if launched, will be commercially successful;
  • The productivity of acquired income generating assets may not fulfill our revenue forecasts and, if secured by collateral, we may be undersecured and unable to recuperate our capital expenditures in the transaction;
  • Changes in any of the other assumptions on which PDL's projected royalty revenues are based;
  • The outcome of pending litigation or disputes, including PDL's current dispute with Genentech related to ex-U.S. sales of Genentech licensed products;
  • The change in foreign currency exchange rate;
  • Positive or negative results in PDL's attempt to acquire income generating assets; and
  • The failure of licensees to comply with existing license agreements, including any failure to pay royalties due.

    • Other factors that may cause PDL's actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are discussed in PDL's filings with the SEC, including the "Risk Factors" sections of its annual report filed with the SEC. Copies of PDL's filings with the SEC may be ob
    '/>"/>

    SOURCE PDL BioPharma, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related medicine technology :

    1. PDL BioPharma to Hold Annual Meeting of Stockholders on May 21, 2013
    2. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
    3. PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results
    4. BiOptix to highlight new carbonic anhydrase data at IBCs Biopharmaceutical Development & Production Week
    5. Array BioPharma To Present At The Cowen Annual Health Care Conference
    6. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
    7. Promise and Problems Signal Mixed Year Ahead for Biopharmaceutical Industry, Says Pharmaceutical Executive Magazine
    8. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
    9. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
    10. Matinas BioPharma to Present at the NYC Medical Technology Forum on February 5, 2013
    11. Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/21/2013)... 2013 New data released today at ... show that the NeuroStar TMS Therapy System ® ... remission in patients with Major Depressive Disorder (MDD) ... maintained through one year of treatment.  At the ... achieved symptomatic improvement while 41 percent reported complete ...
    (Date:5/21/2013)... May 21, 2013 Valeant ... VRX ) (TSX: VRX) today announced ... at its 2013 annual meeting of ... the vote for the election of ... H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo Melas-Kyriazi237,081,508615,174G. Mason ...
    (Date:5/21/2013)... May 21, 2013  Lakeland Industries, Inc. (NASDAQ: ... of industrial protective clothing for industry, municipalities, healthcare ... local levels, today announced that the Company accepted ... Senior Credit Facility subject to certain terms and ... financing.  However, no assurances can be given that ...
    Breaking Medicine Technology:New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 3Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 4Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 5Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 6Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 7Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 8Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 9Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 10Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 11Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 12Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 13
    ... DETROIT, March 22, 2011 The Detroit Medical ... healthcare provider in Michigan to offer a new ... heartbeat) in patients who struggle with this potentially ... state-of-the-art technology – known formally as the "Arctic ...
    ... ReGen Biologics, Inc. (ReGen), manufacturer of the popular and ... and Drug Administration,s (FDA) offer of a hearing under 21 ... rescind clearance of the device. According to ReGen ... experience with the FDA over the past six years makes ...
    Cached Medicine Technology:Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat 2Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat 3Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat 4ReGen to FDA: 'Thanks, But No Thanks' 2ReGen to FDA: 'Thanks, But No Thanks' 3ReGen to FDA: 'Thanks, But No Thanks' 4
    (Date:5/21/2013)... New York (PRWEB) May 21, 2013 ... Wright Conserve hip replacement lawsuits in U.S. ... Order in response to a request from Plaintiffs’ Counsel ... the Defendant. The May 17th Order grants that ... may be conducted. (In re: Wright Medical Technology, Inc., ...
    (Date:5/21/2013)... 21, 2013 The In View ... networks and cable channels across the country, announces it ... YouTube channel. The producers of the series proudly bring ... shipping industry, the manufacturing industry, health-related companies, medical facilities ... and medical practitioners in all parts of the United ...
    (Date:5/21/2013)... Phoseon Technology will present their advanced UV ... European Ink Jet Conference (June 5-6, Barcelona, Spain). ... invest in product development to enable breakthrough capability and ... in printing applications. Phoseon currently has a wide ... air cooled and water cooled solutions to match the ...
    (Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve the ... Creative Corridor region, is releasing results for its 2013 ... Thursday, May 23rd at 10:30 a.m. The survey ... , The survey is a critical component to the ... nurture and retain people of diverse backgrounds, cultures and ...
    (Date:5/21/2013)... 2013 Global Proving Ground (GPG), a ... largest online retailer of health and fitness supplements, are ... show, Warrior Island. “We cast the show by ... Twitter, with our unique social networking platform,” states show’s ... fighters on an island in the Pacific Ocean, where ...
    Breaking Medicine News(10 mins):Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3
    ... out of the pan into the fire itself, the burning ... Government directives to disclose levels of trans fats in packaged ... of trans fat in french fries.// The tests have put ... third more ( 8 grammes as against earlier 6 grams ...
    ... flu has been reported from a chicken farm located in ... // monitored and is believed to be under control, according ... than 15, 000 chickens in a farm (Yijing township), confirmed ... response to the above situation, a special team to combat ...
    ... blood pressure clinical trial is launching a nationwide outreach ... pressure. // This is a follow-up to the Antihypertensive ... and is being launched in collaboration with the National ... ,The ALLHAT blood pressure study had compared the effectiveness ...
    ... people who suffer from the Ischemic Heart Disease (IHD) which ... // person to person, depending upon whether it is ... is affected by this medical condition, and where Western countries ... ,When patients seek medical care for chest pain, diagnosticians ...
    ... M to Kenya by the World Bank for HIV/AIDS education ... as it has been delayed due to some allegations pertaining ... are against the Kenyan government, the SAPA/Mail & Guardian reports ... Ministry of Health in February 2005 it had failed to ...
    ... the February issue of the Journal of Periodontology, says ... developing preeclampsia in pregnancy. // The results of the ... weight babies as compared to women who do not ... more prevalent in the preeclamptic group by almost 64 ...
    Cached Medicine News:Health News:Diuretics More Effective In Controlling High Blood Pressure 2Health News:Gum Disease Associated With Increased Risk of Preeclampsia 2
    ... Platinum is a compact and quiet, ... at 120 psi/8 bar, it provides ... size with noticeable noise reduction. A ... with an enhanced ergonomic handpiece to ...
    Relocatable frame has been designed specifically for fractionated stereotactic radiotherapy treatments. It provides a fast, non-invasive and reproducible fixation of the patient....
    ... Leksell Stereotactic System is the ... the world. Reliability, flexibility, versatility ... features of the Leksell Stereotactic ... on the center-of-arc principle and ...
    Table-mounted, retraction for radiolucent anterior spine procedures. Fully-adjustable for any approach and any patient. Combine with our radiolucent blade kit for optimal visibility....
    Medicine Products: